Pickering-Brown SM - Search Results

1

Apolipoprotein E epsilon4 allele frequency and age at onset of Alzheimer's disease.

Davidson Y, Gibbons L, Pritchard A, Hardicre J, Wren J, Stopford C, Julien C, Thompson J, Payton A, Pickering-Brown SM, Pendleton N, Horan MA, Burns A, Purandare N, Lendon CL, Neary D, Snowden JS, Mann DM. Davidson Y, et al. Dement Geriatr Cogn Disord. 2007;23(1):60-6. doi: 10.1159/000097038. Epub 2006 Nov 14. Dement Geriatr Cogn Disord. 2007. PMID: 17108687 Free article.

2

The extent of amyloid deposition in brain in patients with Down's syndrome does not depend upon the apolipoprotein E genotype.

Mann DM, Pickering-Brown SM, Siddons MA, Iwatsubo T, Ihara Y, Asami-Odaka A, Suzuki N. Mann DM, et al. Neurosci Lett. 1995 Aug 18;196(1-2):105-8. doi: 10.1016/0304-3940(95)11860-y. Neurosci Lett. 1995. PMID: 7501233

3

Apolipoprotein E allelic frequencies in patients with lobar atrophy.

Pickering-Brown SM, Siddons M, Mann DM, Owen F, Neary D, Snowden JS. Pickering-Brown SM, et al. Neurosci Lett. 1995 Mar 31;188(3):205-7. doi: 10.1016/0304-3940(95)11425-v. Neurosci Lett. 1995. PMID: 7609910

4

Apolipoprotein E epsilon 2 allele promotes longevity and protects patients with Down's syndrome from dementia.

Royston MC, Mann D, Pickering-Brown S, Owen F, Perry R, Raghavan R, Khin-Nu C, Tyrer S, Day K, Crook R, et al. Royston MC, et al. Neuroreport. 1994 Dec 20;5(18):2583-5. doi: 10.1097/00001756-199412000-00044. Neuroreport. 1994. PMID: 7696609

5

Allelic variations in apolipoprotein E and prion protein genotype related to plaque formation and age of onset in sporadic Creutzfeldt-Jakob disease.

Pickering-Brown SM, Mann DM, Owen F, Ironside JW, de Silva R, Roberts DA, Balderson DJ, Cooper PN. Pickering-Brown SM, et al. Neurosci Lett. 1995 Mar 3;187(2):127-9. doi: 10.1016/0304-3940(95)11353-3. Neurosci Lett. 1995. PMID: 7783958

6

Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other beta-amyloid-forming diseases.

Pickering-Brown SM, Mann DM, Bourke JP, Roberts DA, Balderson D, Burns A, Byrne J, Owen F. Pickering-Brown SM, et al. Lancet. 1994 May 7;343(8906):1155. doi: 10.1016/s0140-6736(94)90257-7. Lancet. 1994. PMID: 7818636 No abstract available.

7

Debrisoquine hydroxylase gene polymorphism frequencies in patients with amyotrophic lateral sclerosis.

Siddons MA, Pickering-Brown SM, Mann DM, Owen F, Cooper PN. Siddons MA, et al. Neurosci Lett. 1996 Apr 12;208(1):65-8. doi: 10.1016/0304-3940(96)12549-0. Neurosci Lett. 1996. PMID: 8731176

8

Preferential deposition of amyloid beta protein (Abeta) in the form Abeta40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele.

Mann DM, Iwatsubo T, Pickering-Brown SM, Owen F, Saido TC, Perry RH. Mann DM, et al. Neurosci Lett. 1997 Jan 17;221(2-3):81-4. doi: 10.1016/s0304-3940(96)13294-8. Neurosci Lett. 1997. PMID: 9121705

9

An intronic polymorphism in the presenilin-1 gene does not influence the amount or molecular form of the amyloid beta protein deposited in Alzheimer's disease.

Mann DM, Pickering-Brown SM, Bayatti NN, Wright AE, Owen F, Iwatsubo T, Saido TC. Mann DM, et al. Neurosci Lett. 1997 Jan 24;222(1):57-60. doi: 10.1016/s0304-3940(97)13342-0. Neurosci Lett. 1997. PMID: 9121723

10

Effect of apolipoprotein E status on clinical features of dementia.

Burlinson S, Burns A, Mann D, Pickering-Brown S, Owen F. Burlinson S, et al. Int J Geriatr Psychiatry. 1998 Mar;13(3):177-85. doi: 10.1002/(sici)1099-1166(199803)13:3<177::aid-gps758>3.0.co;2-m. Int J Geriatr Psychiatry. 1998. PMID: 9565840

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

189 results

Search Page